Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer

Background: Mesothelin is expressed in various types of malignant tumour, and we recently reported that expression of mesothelin was related to an unfavourable patient outcome in pancreatic ductal adenocarcinoma. In this study, we examined the clinicopathological significance of the mesothelin expre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2012-06, Vol.107 (1), p.137-142
Hauptverfasser:	Einama, T, Homma, S, Kamachi, H, Kawamata, F, Takahashi, K, Takahashi, N, Taniguchi, M, Kamiyama, T, Furukawa, H, Matsuno, Y, Tanaka, S, Nishihara, H, Taketomi, A, Todo, S
Format:	Artikel
Sprache:	eng
Schlagworte:	692/53/2422 692/699/67/1504/1829 Aged Antibodies Antigens Biological and medical sciences Biomarkers, Tumor - metabolism Biomedical and Life Sciences Biomedicine Blood vessels Cancer Research Clinical outcomes Drug Resistance Epidemiology Epithelial Cells - metabolism Female Gastric cancer Gastroenterology. Liver. Pancreas. Abdomen GPI-Linked Proteins - metabolism Humans Immunohistochemistry Localization Lymph Nodes - metabolism Lymphatic Metastasis Male Medical research Medical sciences Medicine Middle Aged Molecular Diagnostics Molecular Medicine Oncology Ovarian cancer Pancreatic cancer Pathology Patients Stomach Neoplasms - metabolism Stomach Neoplasms - mortality Stomach Neoplasms - pathology Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Surgery Survival Analysis Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!